Prediction Case File
YouTubeTracking Live

MRK Merck Stock: Monday Predicted Opening Price & 5 Price Targets After Keytruda FDA Win? πŸ”₯

1 extracted signal Β· 0 resolved Β· 1 still active

StockInvest.us profile imageStockInvest.us13 Jul 2026, 12:55 UTC
Video preview for MRK Merck Stock: Monday Predicted Opening Price & 5 Price Targets After Keytruda FDA Win? πŸ”₯
Signals
1
Eligible signals in this source
Open
1
Still being tracked
Resolved
0
Evaluable outcomes
Successful
0
Canonical correct result
Failed
0
Canonical failed result
Resolved success
Not enough data
Open and excluded signals omitted
Source overview

AI-generated source summary

Merck (MRK) is exhibiting a bullish trend, supported by its 50-day and 200-day moving averages, which are currently above the stock price. The price has shown a significant gain of 3.29% over the past 13 days, with an average daily gain of 0.25%. Technical indicators suggest a potential increase of 11% over the next three months, and a 53%-71% increase over the next year. The stock is currently trading at $123.54, with a support level identified at $119.60 and a resistance level at $125.45. A sell signal was issued five days ago from a pivot top, indicating potential downward pressure if the support level is breached. The current price-to-earnings (P/E) ratio of 34.70 is considered relatively normal for established companies. Analyst ratings are mixed, with a general sentiment of 'neutral' overall, but specific ratings include 'Buy' from Guggenheim and HSBC, and 'Overweight' from Wells Fargo, all recommending a 'Hold' action. The latest insider trading data shows a positive sentiment with a high insider power of 77.884, indicating significant insider buying activity.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

StockInvest.us

Tracked signals
1521
Historical success
43.3%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.